The impact of Haemophilus influenzae type b vaccination in Sweden

Scand J Infect Dis. 1996;28(2):165-9. doi: 10.3109/00365549609049069.

Abstract

The number of patients with meningitis and bacteremia due to Haemophilus influenzae was studied in Sweden over the period 1987-1994. Conjugated H. influenzae type b vaccines were introduced in Sweden in 1992, and all children born after December 31, 1992, were offered vaccination free of charge. A rapid decline of H. influenzae meningitis and bacteraemia was observed in the autumn of 1993, when the expected peak incidence failed to appear. In the prevaccination period 1987-1991, the average annual incidence (cases/100,000) was 34.4 in children aged 0-4 years. In 1994, the annual incidence fell to 3.5. No significant decline was observed in older children or adults. There was a 92% reduction in the number of meningitis cases and an 83% reduction in cases of bacteraemia. A similar decline was noted in 2 regions which followed different strategies for the introduction of the vaccination programme.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Bacteremia / epidemiology
  • Bacteremia / prevention & control*
  • Bacterial Capsules
  • Child, Preschool
  • Haemophilus Infections / epidemiology
  • Haemophilus Infections / prevention & control*
  • Haemophilus Vaccines / administration & dosage*
  • Haemophilus Vaccines / adverse effects
  • Humans
  • Immunization Programs* / trends
  • Incidence
  • Infant
  • Infant, Newborn
  • Linear Models
  • Meningitis, Haemophilus / epidemiology
  • Meningitis, Haemophilus / prevention & control*
  • Polysaccharides, Bacterial / administration & dosage*
  • Polysaccharides, Bacterial / adverse effects
  • Sweden / epidemiology

Substances

  • Haemophilus Vaccines
  • Haemophilus influenzae type b polysaccharide vaccine
  • Polysaccharides, Bacterial